These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 26471359)

  • 41. In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer.
    Carugo A; Genovese G; Seth S; Nezi L; Rose JL; Bossi D; Cicalese A; Shah PK; Viale A; Pettazzoni PF; Akdemir KC; Bristow CA; Robinson FS; Tepper J; Sanchez N; Gupta S; Estecio MR; Giuliani V; Dellino GI; Riva L; Yao W; Di Francesco ME; Green T; D'Alesio C; Corti D; Kang Y; Jones P; Wang H; Fleming JB; Maitra A; Pelicci PG; Chin L; DePinho RA; Lanfrancone L; Heffernan TP; Draetta GF
    Cell Rep; 2016 Jun; 16(1):133-147. PubMed ID: 27320920
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates modulate the expression of p53-MYCN associated micro RNAs in neuroblastoma cells and cause cell cycle arrest and apoptosis.
    Ramaiah MJ; Pushpavalli SN; Lavanya A; Bhadra K; Haritha V; Patel N; Tamboli JR; Kamal A; Bhadra U; Pal-Bhadra M
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5699-706. PubMed ID: 23992861
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serial transcriptome analysis and cross-species integration identifies centromere-associated protein E as a novel neuroblastoma target.
    Balamuth NJ; Wood A; Wang Q; Jagannathan J; Mayes P; Zhang Z; Chen Z; Rappaport E; Courtright J; Pawel B; Weber B; Wooster R; Sekyere EO; Marshall GM; Maris JM
    Cancer Res; 2010 Apr; 70(7):2749-58. PubMed ID: 20233875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. WDR5 associates with histone H3 methylated at K4 and is essential for H3 K4 methylation and vertebrate development.
    Wysocka J; Swigut T; Milne TA; Dou Y; Zhang X; Burlingame AL; Roeder RG; Brivanlou AH; Allis CD
    Cell; 2005 Jun; 121(6):859-72. PubMed ID: 15960974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antitumor activity of the selective MDM2 antagonist nutlin-3 against chemoresistant neuroblastoma with wild-type p53.
    Van Maerken T; Ferdinande L; Taildeman J; Lambertz I; Yigit N; Vercruysse L; Rihani A; Michaelis M; Cinatl J; Cuvelier CA; Marine JC; De Paepe A; Bracke M; Speleman F; Vandesompele J
    J Natl Cancer Inst; 2009 Nov; 101(22):1562-74. PubMed ID: 19903807
    [TBL] [Abstract][Full Text] [Related]  

  • 46. METTL3 orchestrates glycolysis by stabilizing the c-Myc/WDR5 complex in triple-negative breast cancer.
    Yuan XN; Shao YC; Guan XQ; Liu Q; Chu MF; Yang ZL; Li H; Zhao S; Tian YH; Zhang JW; Wei L
    Biochim Biophys Acta Mol Cell Res; 2024 Jun; 1871(5):119716. PubMed ID: 38547933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MYCN/c-MYC-induced microRNAs repress coding gene networks associated with poor outcome in MYCN/c-MYC-activated tumors.
    Mestdagh P; Fredlund E; Pattyn F; Schulte JH; Muth D; Vermeulen J; Kumps C; Schlierf S; De Preter K; Van Roy N; Noguera R; Laureys G; Schramm A; Eggert A; Westermann F; Speleman F; Vandesompele J
    Oncogene; 2010 Mar; 29(9):1394-404. PubMed ID: 19946337
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
    Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
    Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
    Liu C; Fang X; Ge Z; Jalink M; Kyo S; Björkholm M; Gruber A; Sjöberg J; Xu D
    Cancer Res; 2007 Mar; 67(6):2626-31. PubMed ID: 17363582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Up-regulated WDR5 promotes gastric cancer formation by induced cyclin D1 expression.
    Sun W; Guo F; Liu M
    J Cell Biochem; 2018 Apr; 119(4):3304-3316. PubMed ID: 29125890
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The p53 pathway and its inactivation in neuroblastoma.
    Tweddle DA; Pearson AD; Haber M; Norris MD; Xue C; Flemming C; Lunec J
    Cancer Lett; 2003 Jul; 197(1-2):93-8. PubMed ID: 12880966
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo regulation of single copy and amplified N-myc in human neuroblastoma cells.
    Lutz W; Schwab M
    Oncogene; 1997 Jul; 15(3):303-15. PubMed ID: 9233765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A SP1/MIZ1/MYCN repression complex recruits HDAC1 at the TRKA and p75NTR promoters and affects neuroblastoma malignancy by inhibiting the cell response to NGF.
    Iraci N; Diolaiti D; Papa A; Porro A; Valli E; Gherardi S; Herold S; Eilers M; Bernardoni R; Della Valle G; Perini G
    Cancer Res; 2011 Jan; 71(2):404-12. PubMed ID: 21123453
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Small-molecule MDM2 antagonists as a new therapy concept for neuroblastoma.
    Van Maerken T; Speleman F; Vermeulen J; Lambertz I; De Clercq S; De Smet E; Yigit N; Coppens V; Philippé J; De Paepe A; Marine JC; Vandesompele J
    Cancer Res; 2006 Oct; 66(19):9646-55. PubMed ID: 17018622
    [TBL] [Abstract][Full Text] [Related]  

  • 55.
    Zimmerman MW; Liu Y; He S; Durbin AD; Abraham BJ; Easton J; Shao Y; Xu B; Zhu S; Zhang X; Li Z; Weichert-Leahey N; Young RA; Zhang J; Look AT
    Cancer Discov; 2018 Mar; 8(3):320-335. PubMed ID: 29284669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells.
    Fan L; Iyer J; Zhu S; Frick KK; Wada RK; Eskenazi AE; Berg PE; Ikegaki N; Kennett RH; Frantz CN
    Cancer Res; 2001 Feb; 61(3):1073-9. PubMed ID: 11221835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.
    Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X
    J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deregulated Wnt/beta-catenin program in high-risk neuroblastomas without MYCN amplification.
    Liu X; Mazanek P; Dam V; Wang Q; Zhao H; Guo R; Jagannathan J; Cnaan A; Maris JM; Hogarty MD
    Oncogene; 2008 Feb; 27(10):1478-88. PubMed ID: 17724465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Ews/Fli-1 fusion gene changes the status of p53 in neuroblastoma tumor cell lines.
    Rorie CJ; Weissman BE
    Cancer Res; 2004 Oct; 64(20):7288-95. PubMed ID: 15492248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of Myc-induced histone modifications on target chromatin.
    Martinato F; Cesaroni M; Amati B; Guccione E
    PLoS One; 2008; 3(11):e3650. PubMed ID: 18985155
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.